Ninety-day mortality following lung cancer surgery: Outcomes from the English national clinical outcomes audit

Helen Morgan; David Baldwin; Richard Hubbard; Neal Navani; Doug West; Emma Louise O'Dowd

doi:10.1136/thoraxjnl-2021-218308

Ninety-day mortality following lung cancer surgery: Outcomes from the English national clinical outcomes audit

Helen Morgan^*
, David Baldwin
, Richard Hubbard
, Neal Navani
, Doug West
, Emma Louise O'Dowd

^*Corresponding author for this work

Research output: Journal Publication › Article › peer-review

4 Citations (Scopus)

Abstract

Accurately explaining perioperative mortality and risk to patients is an essential part of shared decision making. In the case of lung cancer surgery, the currently available multivariable mortality prediction tools perform poorly, and could mislead patients. Using data from 2004 to 2012, this group has previously produced data tables for 90-day postoperative mortality, to be used as a communication aid in the consenting process. Using National Lung Cancer Clinical Outcomes audit data from 2017 to 2018, we have produced updated early mortality tables, to reflect current thoracic surgery practice.

Original language	English
Pages (from-to)	724-726
Number of pages	3
Journal	Thorax
Volume	77
Issue number	7
DOIs	https://doi.org/10.1136/thoraxjnl-2021-218308
Publication status	Published - 1 Jul 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Free Keywords

Lung Cancer
Thoracic Surgery

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1136/thoraxjnl-2021-218308

Cite this

@article{314e2d883ef14ac38607a6e286aca327,

title = "Ninety-day mortality following lung cancer surgery: Outcomes from the English national clinical outcomes audit",

abstract = "Accurately explaining perioperative mortality and risk to patients is an essential part of shared decision making. In the case of lung cancer surgery, the currently available multivariable mortality prediction tools perform poorly, and could mislead patients. Using data from 2004 to 2012, this group has previously produced data tables for 90-day postoperative mortality, to be used as a communication aid in the consenting process. Using National Lung Cancer Clinical Outcomes audit data from 2017 to 2018, we have produced updated early mortality tables, to reflect current thoracic surgery practice.",

keywords = "Lung Cancer, Thoracic Surgery",

author = "Helen Morgan and David Baldwin and Richard Hubbard and Neal Navani and Doug West and O'Dowd, \{Emma Louise\}",

note = "Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2022",

month = jul,

day = "1",

doi = "10.1136/thoraxjnl-2021-218308",

language = "English",

volume = "77",

pages = "724--726",

journal = "Thorax",

issn = "0040-6376",

publisher = "BMJ Publishing Group",

number = "7",

}

TY - JOUR

T1 - Ninety-day mortality following lung cancer surgery

T2 - Outcomes from the English national clinical outcomes audit

AU - Morgan, Helen

AU - Baldwin, David

AU - Hubbard, Richard

AU - Navani, Neal

AU - West, Doug

AU - O'Dowd, Emma Louise

PY - 2022/7/1

Y1 - 2022/7/1

N2 - Accurately explaining perioperative mortality and risk to patients is an essential part of shared decision making. In the case of lung cancer surgery, the currently available multivariable mortality prediction tools perform poorly, and could mislead patients. Using data from 2004 to 2012, this group has previously produced data tables for 90-day postoperative mortality, to be used as a communication aid in the consenting process. Using National Lung Cancer Clinical Outcomes audit data from 2017 to 2018, we have produced updated early mortality tables, to reflect current thoracic surgery practice.

AB - Accurately explaining perioperative mortality and risk to patients is an essential part of shared decision making. In the case of lung cancer surgery, the currently available multivariable mortality prediction tools perform poorly, and could mislead patients. Using data from 2004 to 2012, this group has previously produced data tables for 90-day postoperative mortality, to be used as a communication aid in the consenting process. Using National Lung Cancer Clinical Outcomes audit data from 2017 to 2018, we have produced updated early mortality tables, to reflect current thoracic surgery practice.

KW - Lung Cancer

KW - Thoracic Surgery

UR - https://www.scopus.com/pages/publications/85131005065

U2 - 10.1136/thoraxjnl-2021-218308

DO - 10.1136/thoraxjnl-2021-218308

M3 - Article

C2 - 35483893

AN - SCOPUS:85131005065

SN - 0040-6376

VL - 77

SP - 724

EP - 726

JO - Thorax

JF - Thorax

IS - 7

ER -

Ninety-day mortality following lung cancer surgery: Outcomes from the English national clinical outcomes audit

Abstract

UN SDGs

Free Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this